Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat
- PMID: 1534911
- DOI: 10.1007/BF02245275
Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat
Abstract
The D2 or D1 dopamine receptor blockers (-)-sulpiride or SCH 23390 antagonized, in a dose dependent manner, the hypermotility induced by the N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801 (0.25 mg/kg IP). MK-801 induced hyperactivity was not detected when rats were observed on days 7, 14 or 21 of 21 daily injections of MK-801. This lack of hyperactivity was also noted 5 days after the last administration of the repeated treatment with MK-801. The hypermotility induced by the D2 dopamine receptor agonist LY 171555 (0.3 mg/kg IP) was reduced 5 days following repeated treatment (21 days) with MK-801, while no change in the behavioral responses to the selective D1 agonist, SKF 38393, or the mixed D1/D2 agent apomorphine was detected. The results, although suggesting the involvement of dopaminergic pathways in the behavioral effect of MK-801, are conflicting with regard to the underlying mechanisms and to the adaptive changes of dopaminergic system following repeated NMDA receptor blockade.
Similar articles
-
Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.Eur J Pharmacol. 1996 Jul 11;308(1):1-12. doi: 10.1016/0014-2999(96)00266-x. Eur J Pharmacol. 1996. PMID: 8836626
-
The NMDA positive modulator D-cycloserine potentiates the neuroleptic activity of D1 and D2 dopamine receptor blockers in the rat.Psychopharmacology (Berl). 1993;110(1-2):165-8. doi: 10.1007/BF02246967. Psychopharmacology (Berl). 1993. PMID: 7870878
-
Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801.J Neural Transm Park Dis Dement Sect. 1992;4(1):15-26. doi: 10.1007/BF02257618. J Neural Transm Park Dis Dement Sect. 1992. PMID: 1531757
-
N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.Neuroscience. 1993 Jun;54(4):1051-61. doi: 10.1016/0306-4522(93)90595-7. Neuroscience. 1993. PMID: 8101981
-
MK-801 and cognitive functions: Investigating the behavioral effects of a non-competitive NMDA receptor antagonist.Psychopharmacology (Berl). 2023 Dec;240(12):2435-2457. doi: 10.1007/s00213-023-06454-z. Epub 2023 Sep 19. Psychopharmacology (Berl). 2023. PMID: 37725119 Free PMC article. Review.
Cited by
-
Involvement of glutamatergic and dopaminergic systems in the reactivity of mice to spatial and non-spatial change.Psychopharmacology (Berl). 1996 Jul;126(1):55-61. doi: 10.1007/BF02246411. Psychopharmacology (Berl). 1996. PMID: 8853217
-
The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.Naunyn Schmiedebergs Arch Pharmacol. 1996 Apr;353(5):517-27. doi: 10.1007/BF00169171. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8740145
-
Chronic treatment with MK-801 affects the behavioral response to both D1 and D2 dopamine agonist in the one-trial inhibitory avoidance.Psychopharmacology (Berl). 1995 Oct;121(3):401-5. doi: 10.1007/BF02246081. Psychopharmacology (Berl). 1995. PMID: 8584624
-
Sensorimotor gating impairments induced by MK-801 treatment may be reduced by tolerance effect and by familiarization in monkeys.Front Pharmacol. 2015 Sep 22;6:204. doi: 10.3389/fphar.2015.00204. eCollection 2015. Front Pharmacol. 2015. PMID: 26441660 Free PMC article.
-
The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.Psychopharmacology (Berl). 1995 Apr;118(3):310-5. doi: 10.1007/BF02245960. Psychopharmacology (Berl). 1995. PMID: 7617824
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous